Skip to main content
. 2014 Jul 31;9(7):e103086. doi: 10.1371/journal.pone.0103086

Figure 2. CGRP immunoreactivity in trigeminal ganglia in vehicle- and RTX- treated rats.

Figure 2

(A) In vehicle-injected rats, CGRP immunoreactivity was evident in scattered small to medium sized neurons within the TG. RTX-treatment diminished CGRP immunoreactivity by 1 week of survival and further reduced positive profiles at two and three-week post RTX-treatment. Scale bar, 200 µm. (B) CGRP immunoreactive cell counts per section in the trigeminal ganglia in vehicle and RTX-treated rats. At all survival times (one, two and three weeks) following RTX treatment, CGRP positive cell counts are significantly reduced compared with vehicle-treated rats. Cell counts represented as mean ± S.E.M. Number of animals per group is indicated.